Dipyridamole + RiociguatContraindicated
Co-administration with dipyridamole is contraindicated because of hypotension.
Source: NLP:riociguat
Dipyridamole Interactions
Brand names: Dipyridamole
Platelet Aggregation Inhibitor
Route: Intravenous
Contraindications
CONTRAINDICATIONS Hypersensitivity to dipyridamole.
Pregnancy & Breastfeeding
Pregnancy Teratogenic Effects – Pregnancy Category B Reproduction studies performed in mice and rats at daily oral doses of up to 125 mg/kg (15.6 times* the maximum recommended daily human oral dose) and in rabbits at daily oral doses of up to 20 mg/kg (2.5 times* the maximum recommended daily human oral dose) have revealed no evidence of impaired embryonic development due to dipyridamole. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human responses, this drug should be used during pregnancy only if clearly needed. * Calculation based on assumed body weight of 50 kg.
9 interactions on record
Dipyridamole increases plasma levels and cardiovascular effects of adenosine. Adjustment of adenosine dosage may be necessary.
Source: NLP:dipyridamole
Potent BCRP, ENT1, and CNT3 transporter inhibitor may alter cladribine bioavailability, intracellular distribution, and renal elimination.
Source: NLP:cladribine
Platelet inhibitor that may enhance risk of hemorrhage. Discontinue prior to Lovenox initiation if possible, or conduct close clinical and laboratory monitoring if coadministration is essential.
Source: NLP:enoxaparin sodium
Dipyridamole increases cardiovascular effects of regadenoson (adenosine A2A-receptor agonist). Risk of cardiovascular side effects may be increased during stress testing.
Source: NLP:dipyridamole
Dipyridamole + Heparin SodiumModerate
Interferes with platelet aggregation and may induce bleeding. Use with caution; dose reduction of antiplatelet agent or heparin recommended.
Source: NLP:heparin sodium
Dipyridamole + Mao InhibitorsModerate
Dipyridamole may counteract anticholinesterase effect of cholinesterase inhibitors, potentially aggravating myasthenia gravis.
Source: NLP:dipyridamole
Dipyridamole + MetoprololUnknown
Drug interaction mentioned but description incomplete in provided text.
Source: NLP:metoprolol
Beta-blocker administration should be withheld before use (interaction mentioned but details incomplete).
Source: NLP:metoprolol tartrate